Evaluación de la saciedad en personas que han sufrido trastornos de la conducta alimentaria

  1. Pinto González, Sandra 1
  2. Martín Gutiérrez, Susana 1
  3. Jáuregui-Lobera, Ignacio 1
  4. Herrero Martín, Griselda 1
  1. 1 Universidad Pablo de Olavide. Sevilla
Journal:
Journal of Negative and No Positive Results: JONNPR

ISSN: 2529-850X

Year of publication: 2019

Volume: 4

Issue: 8

Pages: 806-828

Type: Article

DOI: 10.19230/JONNPR.3158 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Journal of Negative and No Positive Results: JONNPR

Abstract

People who suffer from eating disorders have physiological alterations in the control mechanisms of hunger  and satiety. These mechanisms are regulated by signals from the digestive system, signals from the central nervous system, and informative signals of nutritional and metabolic status. Knowing  these mechanisms and the substances implied in their regulation, we try to understand the possible causes  of these alterations, and their possible changes after overcoming the disorder, differentiating  between Anorexia Nervosa, Bulimia Nervosa and obesity caused by Binge Eating Disorder. The objective of  this review is to evaluate the physiological alterations presented by patients with Anorexia Nervosa,  Bulimia Nervosa and Binge Eating Disorder in the control mechanisms of hunger and satiety during the  development of the eating disorder, and to assess the continuity of these alterations after overcoming  disorder. 

Bibliographic References

  • Vázquez R, López X, Ocampo MT, y Mancilla-Díaz JM. Eating disorders diagnostic: from the DSM-IV to DSM-5. Rev Mex Trastor Aliment. 2015; 6: 108-120.
  • Fairburn CG, Harrison, PJ. Eating disorders. Lancet. 2003; 361(9355): 407–16.
  • Bayón Pérez C, Bonan V. Trastornos de la conducta alimentaria e intervenciones psicoterapéuticas que incorporan mindfulness. En: Miró MT, Simón V, editores. Mindfulness en la práctica clínica. 3ª Edición. Bilbao: Desclée de Brouwer, 2012.
  • Fairburn CG, Shafran R, Cooper Z. A cognitive behavioural theory of anorexia nervosa. Behav Res Ther, 1999 Jan; 37(1): 1-13.
  • Fairburn, CG, Cooper Z, Bohn K, O’Connor ME, Doll H, Palmer RL. The severity and status of eating disorder NOS: implications for DSM-V. Behav Res Ther. 2007 Aug; 45(8): 1705-15.
  • García A. El trastorno por atracón en el DSM-5. Rev Iberoam Psicosom. 2014; 110:70-74.
  • Frühbeck G, Salvador J. Regulación de la ingesta alimentaria: una perspectiva clínica. Endocrinol y Nut. 2005; 52(8): 404-430.
  • Nuñez Hernández VJ, Vargas Cerero EA, Sánchez Madrigal J, Jaramillo E, Martínez Navarro J, Nava A. Nociones sobre fisiología del apetito. Apetito y hambre. Residente. 2014; 9(1): 15-19.
  • Bellisle F, Blundell JE. Satiation, satiety and the control of food intake. 1ª Edición. England Woodhead Pub.; 2013.
  • Palma J-A, Iriarte J. Regulación del apetito: bases neuroendocrinas e implicaciones clínicas. MedClin (Barc). 2012; 139(2): 70–75.
  • Strader AD, Woods SC. Asociación Americana de Gastroenterología Hormonas gastrointestinales e ingesta de alimentos. Rev Gastroenterol Mex. 2005; 70(4): 439-452.
  • Tucci S. Grelina en regulación del apetito y papel en obesidad y trastornos alimentarios: Abordajes terapéuticos. Rev Venez. Endocrinol y Metab. 2008; 6(2): 15-23.
  • Crespo MÁ, González LC, Lozano MG, Paz SF, Pérez MR, Gago EV, et al. Las hormonas gastrointestinales en el control de la ingesta de alimentos. Endocrinol y Nut. 2009; 56(6): 281-351.
  • Eddy KT, Lawson EA, Meade C, Meenaghan E, Horton SE, Misra M, et al. Appetite regulatory hormones in women with anorexia nervosa: Binge-eating/purging versus restricting type. J Clin Psychiatry. 2015 Jan; 76(1): 19-24.
  • Germain N, Galusca B, Le Roux CW, Bossu C, Ghatei MA, Lang F, et al. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr. 2007 Apr; 85(4): 967-71.
  • Schalla MA, Stengel A. The role of ghrelin in anorexia nervosa. Int J Mol Sci. 2018 Jul; 19(7): 2117.
  • Lourenço T. Análisis de la implicación de diferentes factores reguladores del apetito y del estado nutricional en pacientes con Anorexia Nerviosa y en pacientes con bajo peso constitucional. Universidad Autónoma de Madrid. Departamento de medicina. 2007.
  • González ME, Ambrosio KG, Sánchez S. Regulación neuroendocrina del hambre, la saciedad y mantenimiento del balance energético. Invest Salud. 2006 Dic; 8(3): 191-200.
  • Dalton B, Bartholdy S, Robinson L, Solmi M, Ibrahim MAA, Breen G, et al. A metaanalysis of cytokine concentrations in eating disorders. J Psychiatr Res. 2018 Aug; 103:252-264.
  • Bronsky J, Nedvidkova J, Krasnicanova H, Vesela M, Schmidtova J, Koutek J, et al. Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation. Int J Eat Disord. 2011 Sep; 44(6): 547-52.
  • Romero C, Duarte B, Ginez I, Reboredo T, Ruiz J. et al. Regulación de la ingesta de alimento: una aproximación al sistema endocannabinoide. Acad biomed digit. 2015; 61.
  • Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in bingeeating disorder, but not in bulimia nervosa. Neuropsychopharmacology. 2005 Jun;30(6):1216-21.
  • Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet. 1999 Jan; 21(1):119-22.
  • Vettor R, Fabris R, Pagano C, Federspil G. Neuroendocrine regulation of eating behavior. J Endocrinol Invest. 2002 Nov; 25(10): 836-54.
  • Verdich C, Toubro S, Buemann B, Madsen JL, Holst JJ, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal- induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001 Aug; 25(8): 1206-14.
  • Bessesen DH, Faggioni R. Recently identified peptides involved in the regulation of body weight. Semin Oncol. 1998 Apr; 25(2 Suppl 6): 28- 32.
  • Tanaka M, Naruo T, Muranaga T, Yasuhara D, Shiiya T, Nakazato M, et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol. 2002 Jun; 146 (1): R1-3.
  • Gendall KA, Kaye WH, Altemus M, Conaha CW, La Via MC. Leptin, neuropeptide Y and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry. 1999 Jul; 46(2): 292-9.